Metabolic syndrome and depression;Metabolisches syndrom und depression

Therapeutische Umschau

Volumn 63, Issue 8, 2006, Pages 521-527

  Löwe, Bernd ^a   Hochlehnert, A ^a   Nikendei, C ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOSE; HEMOGLOBIN A1C; LIPID;

ARTICLE; BEHAVIOR; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL FEATURE; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; EUROPE; FAMILY THERAPY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEREDITY; HUMAN; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PREVALENCE; PROBLEM SOLVING; PSYCHOEDUCATION; TREATMENT PLANNING; UNITED STATES; WEIGHT CONTROL; WEIGHT REDUCTION; WELLBEING;

COMORBIDITY; DEPRESSION; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS;

EID: 33748554834     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.63.8.521     Document Type: Article

References (13)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365(9468): 1415-28.
2. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149(7): 1514-20.
3. Alberti KG, Zimmet P, Shaw J, The metabolic syndrome - a new worldwide definition. Lancet 2005; 366(9491): 1059-62.
4. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005; 28(11): 2745-9.
5. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28(7): 1769-78.
6. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9438): 937-52.
7. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28(9): 2289-2304.
8. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004; 78(2): 131-40.
9. Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291(21): 2581-90.
10. Wittchen HU, Pittrow D. Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study. Hum Psychopharmacol 2002; 17 Suppl 1: S1-11.
11. Petrlova B, Rosolova H, Hess Z, Podlipny J, Simon J. Depressive disorders and the metabolic syndrome of insulin resistance. Semin Vasc Med 2004; 4(2): 161-5.
12. Kahl KG. Metabolisches Syndrom und psychische Erkrankungen: Relevanz Risikofaktoren, und praktische Konsequenzen. MMW Fortschr Med 2005; 147(42): 32-4.
13. Ramasubbu R. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses 2002; 59(5): 537-51.